First research of use Vero-Fludarabine in chronic lymphocytic leukemia and non-hodgkins lymphoma
The aim of the investigation was to estimate Vero-Fludarabine in chronic lymphocytic leukemia and non-Hodgkin’s lymphoma patients. We report the activity of three combinations of Vero-Fludarabine, one with cyclophosphamide (Vero-FluCy), the second with cyclophosphamide plus rubida (Vero-FLUCYr) and...
Saved in:
| Main Authors: | S. S. Bessmeltsev, K. M. Abdulkadyrov |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ABV-press
2022-11-01
|
| Series: | Онкогематология |
| Subjects: | |
| Online Access: | https://oncohematology.abvpress.ru/ongm/article/view/678 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Treatment of patients with refractory chronic lymphocytic leukemia with alemtuzumab, alone or in combination with fludarabine
by: E. V. Kataeva, et al.
Published: (2014-07-01) -
Lower Number of Fludarabine Cycles in Patients with Lymphoid Malignancies
by: Donald Pasquale
Published: (2014-08-01) -
Inferior Outcomes of Fludarabine–Cyclophosphamide–Rituximab Chemotherapy in Korean Chronic Lymphocytic Leukemia Patients with Concurrent Thrombocytopenia and Anemia
by: Tong-Yoon Kim, et al.
Published: (2025-01-01) -
ALLOGENEIC TRANSPLANTATION FOR CHRONIC LYMPHOCYTIC LEUKEMIA
by: Luca Laurenti, et al.
Published: (2010-08-01) -
Initial renal function and type of chemotherapy: impact on treatment efficacy in patients with chronic lymphocytic leukemia
by: A. K. Nikitina, et al.
Published: (2015-06-01)